Transition to CFC-free metered dose inhalers--into the new millennium (Q33950447)

30 July 2017

1 reference

title

Transition to CFC-free metered dose inhalers--into the new millennium (English)

1 reference

30 July 2017

McDonald KJ

1

1 reference

PubMed ID

10867268

30 July 2017

Martin GP

series ordinal

2

1 reference

PubMed ID

10867268

30 July 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

International Journal of Pharmaceutics

30 July 2017

1 reference

30 July 2017

201

1 reference

30 July 2017

1

1 reference

30 July 2017

89-107

1 reference

The quantitative determination of aspirin and its degradation products in a model solution aerosol

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

The influence of age on aerosol deposition in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

Low first-spray drug content in albuterol metered-dose inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

Formulation and in vitro evaluation of pressurized inhalation aerosols containing isotropic systems of lecithin and water

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

Large losses of total ozone in Antarctica reveal seasonal ClO x /NO x interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

Particle size distribution of single and multiple sprays of salbutamol metered-dose inhalers (MDIs).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

Pharmacokinetics and dose proportionality of beclomethasone from three strengths of a CFC-free beclomethasone dipropionate metered-dose inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

Chlorofluorocarbon Sources of Environmental Contamination

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

Improved delivery of inhaled steroids to the large and small airways

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

Metered-dose inhalers, I: Drug content and particle size distribution of beclomethasone dipropionate

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

Improper patient techniques with metered dose inhalers: clinical consequences and solutions to misuse.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

Inhaled beclomethasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

Stratospheric sink for chlorofluoromethanes: chlorine atom-catalysed destruction of ozone

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

CFCs, their replacements, and the ozone layer.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

Influence of Formulation on Aerosol Particle Size

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

Review of dry powder inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

Determining equivalence of inhaled medications. Consensus statement from a workshop of the British Association for Lung Research, held at Royal Brompton National Heart & Lung Institute, London 24 June 1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

Inhaled corticosteroids for adult asthma: impact of formulation and delivery device on relative pharmacokinetics, efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

The challenge of reformulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

Metered-dose inhaler formulations with beclomethasone-17,21-dipropionate using the ozone friendly propellant R 134a.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

Variability in size distribution measurements obtained using multiple Andersen Mark II cascade impactors

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

Formulation and evaluation of albuterol metered dose inhalers containing tetrafluoroethane (P134a), a non-CFC propellant

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

Compatibility evaluation of metered-dose inhaler valve elastomers with tetrafluoroethane (P134a), a non-CFC propellant.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

Drug form selection in albuterol-containing metered-dose inhaler formulations and its impact on chemical and physical stability

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

Drug-surfactant-propellant interactions in HFA-formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

Process-induced crystallinity changes in albuterol sulfate and its effect on powder physical stability

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

Influence of metering chamber volume and water level on the emitted dose of a suspension-based pMDI containing propellant 134a

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900401-4

7 January 2021

10.1016/S0378-5173(00)00401-4

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10867268